Ligand Pharmaceuticals
LGND
LGND
196 hedge funds and large institutions have $1.33B invested in Ligand Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 60 increasing their positions, 76 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
20% less capital invested
Capital invested by funds: $1.67B → $1.33B (-$341M)
21% less repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 76
29% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 24
Holders
196
Holding in Top 10
2
Calls
$4.73M
Puts
$839K
Top Buyers
| 1 | +$8.35M | |
| 2 | +$5.76M | |
| 3 | +$5.19M | |
| 4 |
MPAM
Monarch Partners Asset Management
Boston,
Massachusetts
|
+$4.16M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.13M |
Top Sellers
| 1 | -$46.2M | |
| 2 | -$16.9M | |
| 3 | -$7.41M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.38M |
| 5 |
Millennium Management
New York
|
-$4.6M |